Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors

Strahlentherapie und Onkologie

Volumn 188, Issue 2, 2012, Pages 148-153

  Gani, C ^a   Muller A C ^a   Eckert, F ^a   Schroeder, C ^a   Bender, B ^a   Pantazis, G ^a   Bamberg, M ^a   Berger, B ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cumulative survival rate; Leptomeningeal carcinomatosis; Prognostic factors; Solid tumors; Whole brain radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CARCINOMATOUS MENINGITIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGNOSIS; SOLID TUMOR; TREATMENT OUTCOME; WHOLE BRAIN RADIOTHERAPY; BRAIN TUMOR; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; MIDDLE AGED; PALLIATIVE THERAPY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MENINGEAL CARCINOMATOSIS; MIDDLE AGED; PALLIATIVE CARE; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 84858042328     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0025-8     Document Type: Article

References (25)

1. Blaney SM, Poplack DG (2000) Neoplastic meningitis: diagnosis and treatment considerations. Med Oncol 17:151-162
2. Boogerd W, Hart AA, Sande JJ van der, Engelsman E (1991) Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 67:1685-1695
3. Boogerd W, Bent MJ van den, Koehler PJ et al (2004) The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. Eur J Cancer 40:2726-2733
4. Chamberlain MC (2008) Neoplastic meningitis. Oncologist 13:967-977
5. Chamberlain MC (2005) Neoplastic meningitis. J Clin Oncol 23:3605-3613
6. Clamon G, Doebbeling B (1987) Meningeal carcinomatosis from breast cancer: spinal cord vs. brain involvement. Breast Cancer Res Treat 9:213-217
7. Feyer P, Sautter-Bihl ML, Budach W et al (2010) DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis. Strahlenther Onkol 186:63-69
8. Fizazi K, Asselain B, Vincent-Salomon A et al (1996) Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer 77:1315-1323
9. Fokas E, Henzel M, Engenhart-Cabillic R (2010) A comparison of radiotherapy with radiotherapy plus surgery for brain metastases from urinary bladder cancer: analysis of 62 patients. Strahlenther Onkol 186:565-571
10. Glantz MJ, Cole BF, Recht L et al (1998) High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 16:1561-1567
11. Glantz MJ, Jaeckle KA, Chamberlain MC et al (1999) A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5:3394-3402
12. Grossman SA, Finkelstein DM, Ruckdeschel JC et al (1993) Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol 11:561-569
13. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25:103-119
14. Heisterkamp C, Haatanen T, Schild SE, Rades D (2010) Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer. Strahlenther Onkol 186:70-75
15. Hermann B, Hultenschmidt B, Sautter-Bihl ML (2001) Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis. Strahlenther Onkol 177:195-199
16. Herrlinger U, Forschler H, Kuker W et al (2004) Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 223:167-178
17. Jayson GC, Howell A, Harris M et al (1994) Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant. Cancer 74:3135-3141
18. Oechsle K, Lange-Brock V, Kruell A et al (2010) Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. J Cancer Res Clin Oncol 136:1729-1735
19. Pentheroudakis G, Pavlidis N (2005) Management of leptomeningeal malignancy. Expert Opin Pharmacother 6:1115-1125
20. Sas-Korczynska B, Korzeniowski S, Wojcik E (2010) Comparison of the effectiveness of "late" and "early" prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. Strahlenther Onkol 186:315-319
21. Sause WT, Crowley J, Eyre HJ et al (1988) Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases-a Southwest Oncology Group study. J Neurooncol 6:107-112
22. Taillibert S, Hildebrand J (2006) Treatment of central nervous system metastases: parenchymal, epidural, and leptomeningeal. Curr Opin Oncol 18:637-643
23. Wasserstrom WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759-772
24. Watanabe M, Tanaka R, Takeda N (1993) Correlation of MRI and clinical features in meningeal carcinomatosis. Neuroradiology 35:512-515
25. Weller M (2005) Leitlinie zur Diagnostik und Therapie der Meningeosis neoplastica der Neuro-Onkologischen Arbeitsgemeinschaft (NOA) und der Arbeitsgemeinschaft Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft (11/2005, http://www.neuroonkologie.de/fileadmin/ neuroonkologie/pdf/leitmeni.pdf). Accessed 14 December 2011